Insider plans sale of 5,608 common shares

A holder of common stock has filed a Form 144 indicating an intent to sell 5,608 shares through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 01/20/2026 and an aggregate market value of $30,563.60.

Rhea-AI Filing Summary

A holder of common stock has filed a Form 144 indicating an intent to sell 5,608 shares through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 01/20/2026 and an aggregate market value of $30,563.60. These shares were acquired as restricted stock units from the issuer on 04/18/2024.

The notice also lists recent Rule 10b5-1 sales for Philippe Menu, including 5,000–5,006-share transactions on 01/12/2026 and 01/06/2026 and several smaller sales in late 2025, with disclosed gross proceeds for each trade. The filing notes that total common shares outstanding are 67,847,058 at the time of the planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SOPH Form 144 filing disclose?

The Form 144 discloses a planned sale of 5,608 shares of common stock on the NASDAQ, with an aggregate market value of $30,563.60, to be executed through Morgan Stanley Smith Barney.

Who is associated with the planned SOPH share sale?

The filing lists Philippe Menu in connection with past Rule 10b5-1 sales of common stock and identifies common shares acquired from the issuer as restricted stock units.

How many SOPH shares were acquired and when?

The holder acquired 5,608 common shares as restricted stock units from the issuer on 04/18/2024, with the same amount shown as the planned sale quantity.

What recent 10b5-1 sales are reported for SOPH stock?

Recent 10b5-1 sales for Philippe Menu include trades on 01/12/2026 (5,000 shares for $25,622.50) and 01/06/2026 (5,006 shares for $23,885.13), plus several smaller sales in late 2025.

How many SOPH common shares are outstanding?

The filing states that there are 67,847,058 common shares outstanding at the time of the planned sale.

On which exchange will the SOPH shares be sold?

The planned 5,608-share sale of common stock is listed as occurring on the NASDAQ exchange.

Which broker is handling the planned SOPH share sale?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the planned sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014308
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	PHILIPPE MENU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5608	30563.60	67847058	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/18/2024	Restricted Stock Units	Issuer			5608	04/18/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PHILIPPE MENU La Piece 12 ch-1180 Rolle V8 00000	Common	01/12/2026	5000	25622.50
10b5-1 Sales for PHILIPPE MENU La Piece 12 ch-1180 Rolle V8 00000	Common	01/06/2026	5006	23885.13
10b5-1 Sales for PHILIPPE MENU La Piece 12 ch-1180 Rolle V8 00000	Common	12/19/2025	608	2815.04
10b5-1 Sales for PHILIPPE MENU La Piece 12 ch-1180 Rolle V8 00000	Common	11/19/2025	609	2447.75
10b5-1 Sales for PHILIPPE MENU La Piece 12 ch-1180 Rolle V8 00000	Common	10/30/2025	2236	11011.85

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 04/18/2024 through 01/18/2026.
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Philippe Menu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)